Publication date: 12 March 2018
Source:Cancer Cell, Volume 33, Issue 3
Author(s): Joshua J. Waterfall, Paul S. Meltzer
Disruptions in the antagonistic balance between the chromatin-modifying Polycomb and Trithorax group proteins drive many malignancies. In this issue of Cancer Cell, Banito et al. describe how the SS18-SSX oncogenic fusion protein in synovial sarcoma directly co-opts these complexes to drive gene dysregulation and sustain the transformed state.
Teaser
Disruptions in the antagonistic balance between the chromatin-modifying Polycomb and Trithorax group proteins drive many malignancies. In this issue of Cancer Cell, Banito et al. describe how the SS18-SSX oncogenic fusion protein in synovial sarcoma directly co-opts these complexes to drive gene dysregulation and sustain the transformed state.from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2IjLfDs
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου